Pathomorphological and immunohistochemical research methods for multifocal atherosclerosis

Authors

Keywords:

multifocal atherosclerosis, angiogenesis, VEGFR, CD31, Ki-67, Bcl-2, immunohistochemistry, atherosclerotic plaque, cerebral stroke, myocardial infarction, aorta, fibrolipomatosis.

Abstract

For the first time, a comprehensive assessment of the expression of angiogenesis (VEGFR, CD31), proliferation (Ki-67), and apoptosis (Bcl-2) markers was performed in the population of the Aral Sea region with multifocal atherosclerosis, which allowed identifying their pathogenetic interrelation and role in the formation of atherosclerotic plaque instability. It was proven that a combined increase in VEGFR and CD31 expression reflects active neoangiogenesis, whereas an increase in Ki-67 and Bcl-2 indicates the activation of proliferative and anti-apoptotic processes contributing to disease progression.

Aim: To comprehensively study the pathomorphological, immunohis-tochemical, and ultrastructural features of multifocal atherosclerosis in the Aral Sea region by determining the expression of key markers of angiogenesis (VEGFR, CD31), cell proliferation (Ki-67), and apoptosis (Bcl-2) in the vascular wall of patients, as well as to determine their pathogenetic and diagnostic significance for developing an effective algorithm for early diagnosis, risk stratification, and disease prognosis.

Material and Methods: The study was carried out on the basis of pathological and clinical departments using morphological, immunohistochemical, ultrastructural, and analytical methods. Vascular wall specimens (coronary arteries, aorta, carotid, and peripheral arteries) obtained during surgical interventions and autopsy examinations served as the material for the study.

Results: Immunohistochemical examination revealed increased expression of angiogenesis, proliferation, and apoptosis markers: high VEGFR expression was observed in 51 (68.0%) patients, CD31—with an increase in microvessel density—in 53 (70.7%) cases; the Ki-67 proliferation index averaged 19.6%, with high values recorded in 32 (42.6%) observations, and Bcl-2 expression was increased in 44 (58.6%) patients. Significant correlations were found between VEGFR and CD31 (r=0.61), as well as between Ki-67 and Bcl-2 (r=0.57) (p<0.05).

Conclusion: It has been proven that the leading pathogenetic mechanisms of disease progression are the activation of angiogenesis, increased proliferative activity, and suppression of apoptosis, which is confirmed by increased expression of VEGFR in 51 (68.0%), CD31 in 53 (70.7%), Ki-67 in 32 (42.6%), and Bcl-2 in 44 (58.6%) patients. The identified correlations between these markers indicate their complex role in the formation of atherosclerotic plaque instability.

References

Арутюнов А. Г. и др. Мультифокальный атеросклероз: фокус на профилактике развития ишемических событий //Российский кардиологический журнал. – 2021. – №. 12. – С. 163-170.

Ершова А. И. и др. Атеросклеротическая бляшка в сонных артериях как маркер риска развития сердечно-сосудистых событий в популяции среднего возраста //Кардиоваскулярная терапия и профилактика. – 2018. – Т. 17. – №. 4. – С. 34-39.

Жаткина М. В. и др. Мультифокальный атеросклероз: диагностика с помощью пробы Целермайера //Кардиоваскулярная терапия и профилактика. – 2020. – Т. 19. – №. 5. – С. 163-169.

Калинин Р. Е. и др. Биомаркеры апоптоза и пролиферации клеток в диагностике прогрессирования атеросклероза в различных сосудистых бассейнах //Российский медико-биологический вестник имени академика ИП Павлова. – 2022. – Т. 30. – №. 2. – С. 243-252.

Михайлов К. М. и др. Морфологические и гистологические изменения лучевой артерии человека при мультифокальном атеросклерозе //Вестник хирургии имени ИИ Грекова. – 2021. – Т. 180. – №. 5. – С. 12-19.

Мунтяну А. И., Райка М., Зота Е. Г. Иммуногистохимическое изучение роли мастоцитов и макрофагов в процессе патогенеза в атеросклеротических бляшках у пациентов с метаболическим синдромом //Архив патологии. – 2016. – Т. 78. – №. 2. – С. 19-28.

Слатова Л. Н. Значение мультифокального атеросклероза для определения отдалённого прогноза у пациентов после инфаркта миокарда: клинические и морфологические аспекты //Матер. VII Всерос. конфер. Противоречия современной кардиологии: спорные и нерешенные вопросы. – 2018. – С. 83-84.

Султонов О. А. и др. Мултифокал атреосклерозда интракраниал артерияларда юзага келадиган мултиплексли конфокал морфометрик ўзгаришлар //Болезни кровообращения. – 2025. – Ж. 1. – №. 3. – Б. 44-54.

Хасанов А. Х. и др. Влияние эндотелиальной дисфункции на гендерно-сосудистую и нейрокогнитивную гетерогенность при мультифокальном атеросклерозе у пожилых пациентов //Profilakticheskaya Meditsina. – 2019. – Т. 22. – №. 4. – С. 129-137

Хохлюк Е. В. и др. Мультифокальный атеросклероз как прокси болезнь старения //Современные проблемы здравоохранения и медицинской статистики. – 2025. – №. 2. – С. 361-381.

Almeida S. O., Budoff M. Effect of statins on atherosclerotic plaque //Trends in cardiovascular medicine. – 2019. – Vol. 29. – №. 8. – pp. 451-455.

Barrett H. E. et al. Calcifications in atherosclerotic plaques and impact on plaque biomechanics //Journal of biomechanics. – 2019. – Vol. 87. – pp. 1-12.

Genkel V. et al. Associations between Circulating VEGFR2hi‐neutrophils and carotid plaque burden in patients aged 40‐64 without established atherosclerotic cardiovascular disease //Journal of Immunology research. – 2022. – Vol. 2022. – №. 1. – pp. 1539935.

Huynh T. N. M. et al. Circulating CD31 and resistin levels reflect different stages of coronary atherosclerosis in patients with psoriasis //The Journal of Dermatology. – 2025. – Vol. 52. – №. 1. – pp. 67-78.

Mohmand-Borkowski A., Rozmyslowicz T. Immunohistochemical localization of fibroblast activation protein in coronary arteries with different forms of atherosclerosis //Metabolites. – 2024. – Vol. 14. – №. 11. – pp. 573.

Stefanadis C. et al. Coronary atherosclerotic vulnerable plaque: current perspectives //Journal of the American Heart Association. – 2017. – Vol. 6. – №. 3. – pp. e005543.

Tawakol A., Sosnovik D. E. Multiparametric molecular imaging of atherosclerosis: insights into disease pathology and risk //Circulation: Cardiovascular Imaging. – 2020. – Vol. 13. – №. 3. – pp. e010494.

Xu F., Yao F., Ning Y. MicroRNA-202-5p-dependent inhibition of Bcl-2 contributes to macrophage apoptosis and atherosclerotic plaque formation //Gene. – 2023. – Vol. 867. – pp. 147366.

Published

2026-10-15

Versions

How to Cite

1.
Avezov A, Nishanov D, Urunbayeva N, Aytimova G. Pathomorphological and immunohistochemical research methods for multifocal atherosclerosis. MMI [Internet]. 2026 Oct. 15 [cited 2026 Nov. 19];1(1):1-9. Available from: https://urdti-mmi.uz/index.php/MMI/article/view/1